Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
HQ Netherlands · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products not yet catalogued.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
No adverse media involving Nedap Healthcare found in HSH's search of the last 24 months.
No data breaches or cyber incidents involving Nedap Healthcare found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Care records software supplier; no regulatory or clinical safety actions found in the last 24 months.
Oct 2026: parent Nedap N.V. reported Q3 2026 healthcare revenue growth, with more disability and elderly care organisations adopting its care records. No disputes or terminations found in HSH's search of the last 24 months.
No competitors linked yet.